Charleston Laboratories, Inc. Email Format

Pharmaceutical ManufacturingFlorida, United States2-10 Employees

Charleston Laboratories, Inc. is a specialty pharmaceutical company focused on researching and developing novel pain products that aim to prevent or significantly reduce nausea and vomiting, common burdens linked to opioid analgesics and other pain-related conditions. Its programs address opioid-induced nausea and vomiting, postoperative nausea and vomiting, chemotherapy-induced nausea and vomiting, radiation-induced nausea and vomiting, and migraine-induced nausea and vomiting, while pursuing acetaminophen-free formulations to reduce liver injury risk alongside abuse-deterrent technologies. The company intends to form discovery and commercialization alliances with partners to bring these therapies to market.

It is based in Jupiter, Florida. The organization has announced leadership appointments in 2017, including a Vice President of Global Regulatory Affairs & Quality Assurance and a Chief Medical Officer. Earlier, in 2014, Charleston Laboratories announced the CL-108 Phase 3 study and published an abstract reporting reductions in opioid-induced nausea and vomiting.

Sign up for free to view info

Company overview Employee directory